(QDEL) Quidel - Ratings and Ratios

QuidelOrtho Corporation (NASDAQ:QDEL) is a leading provider of diagnostic testing solutions, operating through four core business units: Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics. The Labs division offers clinical chemistry and immunoassay instruments, providing critical data for patient health evaluation and disease management. This includes tests for biomarkers, hormones, and infectious diseases. The Transfusion Medicine unit specializes in blood typing and donor screening, ensuring compatibility and safety in transfusions. The Point of Care division delivers rapid diagnostic solutions for settings like physician offices, hospitals, and retail clinics, enabling timely decision-making. The Molecular Diagnostics unit focuses on PCR-based systems for infectious disease testing, including syndromic panels that detect multiple pathogens simultaneously.

The company distributes its products through a direct sales force and a global network of distributors, serving healthcare providers, laboratories, and consumers. Its products are used in diverse settings, from clinical laboratories to over-the-counter (OTC) consumer health applications. QuidelOrtho operates globally, with a strong presence in North America, Europe, the Middle East, Africa, and China. Founded in 1979 and headquartered in San Diego, California, the company has established itself as a key player in the in-vitro diagnostics industry, with a focus on innovation and accessibility in diagnostic testing solutions.